Centre of Preventive Doping Research, Dept. of Molecular and Cellular Sports Medicine, German Sport University Cologne, Cologne, Germany.
Mol Cell Endocrinol. 2010 Dec 15;330(1-2):1-9. doi: 10.1016/j.mce.2010.08.015. Epub 2010 Aug 27.
Myostatin propeptide (MYOPRO) and follistatin (FOLLI) are potent myostatin inhibitors. In this study we analysed effects of training and androgens on MYOPRO and FOLLI concentrations in blood and skeletal muscle using Immuno PCR. Young healthy males performed either a 3-month endurance training or a strength training. Blood and biopsy samples were analysed. Training did not significantly affect MYOPRO and FOLLI concentrations in serum and muscle. To investigate whether total skeletal muscle mass may affect circulating MYOPRO and FOLLI levels, blood samples of tetraplegic patients, untrained volunteers and bodybuilders were analysed. MYOPRO was significantly increased exclusively in the bodybuilder group. In orchiectomised rats MYOPRO increased in blood and muscle after treatment with testosterone. In summary our data demonstrate that moderate training does not affect the concentrations of MYOPRO to FOLLI. In contrast androgen treatment results in a significant increase of MYOPRO in skeletal muscle and serum.
肌抑素前肽 (MYOPRO) 和卵泡抑素 (FOLLI) 是强效的肌抑素抑制剂。在这项研究中,我们使用免疫聚合酶链反应分析了训练和雄激素对血液和骨骼肌中 MYOPRO 和 FOLLI 浓度的影响。年轻健康的男性进行了为期 3 个月的耐力训练或力量训练。分析了血液和活检样本。训练并没有显著影响血清和肌肉中的 MYOPRO 和 FOLLI 浓度。为了研究总骨骼肌质量是否会影响循环中的 MYOPRO 和 FOLLI 水平,分析了四肢瘫痪患者、未经训练的志愿者和健美运动员的血液样本。仅在健美运动员组中,MYOPRO 显著增加。在去势大鼠中,用睾酮治疗后,血液和肌肉中的 MYOPRO 增加。总之,我们的数据表明,适度的训练不会影响 MYOPRO 到 FOLLI 的浓度。相比之下,雄激素治疗会导致骨骼肌和血清中 MYOPRO 的显著增加。